Atlas Trials

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Clinical trial NCT06519565 · RECRUITING

Trial details

NCT number
NCT06519565
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2024-08-20
Primary completion
2026-12-15
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.